Form 6-K GSK PLC For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
UBS Downgrades GlaxoSmithKline (GSK) to Sell
November 11, 2022 8:54 AM ESTUBS analyst Michael Leuchten downgraded GlaxoSmithKline (NYSE: GSK) from Neutral to Sell.
The analyst comments "At face value GSK trades on c9x '23E PE for near double-digit EPS CAGR to '26. Compared to the EU peer group that may not seem demanding, but we think it is. We see two factors posing risks to the earnings... More
